Association Between Artificial Intelligence Based Chest Computed Tomography and Clinical/Laboratory Characteristics with Severity and Mortality in COVID-19 Hospitalized Patients
DOI: https://doi.org/10.2147/jir.s456440
IF: 4.5
2024-05-15
Journal of Inflammation Research
Abstract:Jiawei Ye, 1, &ast Yingying Huang, 2, &ast Caiting Chu, 3 Juan Li, 1 Guoxiang Liu, 1 Wenjie Li, 1 Chengjin Gao 1 1 Department of Emergency Medicine, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, People's Republic of China; 2 Dementia Research Centre, Faculty of Medicine, Health and Human Sciences, Macquarie University Sydney, Australia; 3 Department of Radiology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chengjin Gao; Wenjie Li, Email ; Background: Some patients with COVID-19 rapidly develop respiratory failure or mortality, underscoring the necessity for early identification of those prone to severe illness. Numerous studies focus on clinical and lab traits, but only few attend to chest computed tomography. The current study seeks to numerically quantify pulmonary lesions using early-phase CT scans calculated through artificial intelligence algorithms in conjunction with clinical and laboratory helps clinicians to early identify the development of severe illness and death in a group of COVID-19 patients. Methods: From December 15, 2022, to January 30, 2023, 191 confirmed COVID-19 patients admitted to Xinhua Hospital Affiliated with Shanghai Jiao Tong University School of Medicine were consecutively enrolled. All patients underwent chest CT scans and serum tests within 48 hours prior to admission. Variables significantly linked to critical illness or mortality in univariate analysis were subjected to multivariate logistic regression models post collinearity assessment. Adjusted odds ratio, 95% confidence intervals, sensitivity, specificity, Youden index, receiver-operator-characteristics (ROC) curves, and area under the curve (AUC) were computed for predicting severity and in-hospital mortality. Results: Multivariate logistic analysis revealed that myoglobin (OR = 1.003, 95% CI 1.001– 1.005), APACHE II score (OR = 1.387, 95% CI 1.216– 1.583), and the infected CT region percentage (OR = 113.897, 95% CI 4.939– 2626.496) independently correlated with in-hospital COVID-19 mortality. Prealbumin stood as an independent safeguarding factor (OR = 0.965, 95% CI 0.947– 0.984). Neutrophil counts (OR = 1.529, 95% CI 1.131– 2.068), urea nitrogen (OR = 1.587, 95% CI 1.222– 2.062), SOFA score(OR = 3.333, 95% CI 1.476– 7.522), qSOFA score(OR = 15.197, 95% CI 3.281– 70.384), PSI score(OR = 1.053, 95% CI 1.018– 1.090), and the infected CT region percentage (OR = 548.221, 95% CI 2.615– 114,953.586) independently linked to COVID-19 patient severity. Keywords: COVID-19, chest CT, artificial intelligence, mortality, severity Coronavirus disease 19 (COVID-19), caused by the Severe Acute Respiratory Coronavirus-2 (SARS-CoV-2), has emerged as a global pandemic and the most significant public health crisis of the 21st century. 1 As of March 1, 2023, the global count surpasses 700 million confirmed COVID-19 cases with over 7 million reported deaths. 2 China experienced a minor peak in COVID-19 transmission in December 2022 due to adjustments in epidemic prevention policies. Existing research reveals that the occurrence of severe COVID-19 cases among all patients is approximately 15%. 3 The mortality rate in severe cases varies from 8.0% to 61.5%, notably higher among elderly patients. 4,5 Early medical intervention is crucial in reducing the mortality rate among severe cases. Thus, timely and accurate identification of risk factors predicting severity and high mortality risk is imperative. Several risk factors contributing to severe COVID-19 and increased morbidity have been identified, including advanced age, male gender, pre-existing health conditions, and racial/ethnic disparities. 6 A systematic review of 61 cohort studies comprising 31,089 hospitalized COVID-19 patients demonstrated elevated mortality risks linked to underlying chronic kidney disease, cardiovascular disease, cerebrovascular disease, chronic obstructive pulmonary disease, hypertension, malignancy, diabetes, and immunodeficiency. 7 A study including 3322 COVID-19 cases in Stockholm revealed a higher mortality risk in patients with heart failure, ischemic heart disease, obesity, type II diabetes, and kidney failure. 8 Previous observational studies, however, were constrained by limited sample sizes, potential biases, and a focus on specific risk factors, 9,10 often lacking comprehensive CT imaging features and quantification(use values instead of descriptions to reflect the situation -Abstract Truncated-
immunology